Pancreatic cancer: Progress made

References

• American Cancer Society. Cancer Statistics, 2009. CA Cancer J Clin 2009;59:225–49.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200–10.
   PubMed Web of Science ®Google Scholar
• Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006; 244:10–5.
   PubMed Web of Science ®Google Scholar
• Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, Wiesenauer CA, . Pancreaticoduodenectomy: A 20-year experience in 516 patients. Arch Surg 2004;139: 718–25.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173–80.
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117–27.
   PubMed Web of Science ®Google Scholar
• Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6:2969–72.
   PubMed Web of Science ®Google Scholar
• Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 2007;171: 263–73.
   PubMed Web of Science ®Google Scholar
• Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, . Cystic pancreatic neoplasms: Observe or operate. Ann Surg 2004;239:651–7; Discussion 657–9.
   PubMed Web of Science ®Google Scholar
• Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, . Intraductal papillary mucinous neoplasms: Predictors of malignant and invasive pathology. Ann Surg. 2007;246:644–51.
   PubMed Web of Science ®Google Scholar
• Canto MI. Screening and surveillance approaches in familial pancreatic cancer. Gastrointest Endosc Clin N Am 2008;18: 535–53, x.
   PubMedGoogle Scholar
• Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, . Pancreatic cancer-associated diabetes mellitus: Prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008;134:95–101.
   PubMed Web of Science ®Google Scholar
• Ritts RE, Pitt HA. CA 19-9 in pancreatic cancer. Surg Oncol Clin N Am. 1998;7:93–101.
   PubMedGoogle Scholar
• Tamm EP, Bhosale PR, Lee JH. Pancreatic ductal adenocarcinoma: Ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007;28:330–8.
   PubMed Web of Science ®Google Scholar
• Heinrich S, Goerres GW, Schäfer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, . Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg. 2005;242:235–43.
   PubMed Web of Science ®Google Scholar
• Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, . Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg. 2001;234:47–55.
   PubMed Web of Science ®Google Scholar
• Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: A systematic review. Clin Gastroenterol Hepatol. 2006;4:717–25.
   PubMed Web of Science ®Google Scholar
• Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, . Pancreatic tumors: Comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998;170:1315–22.
   PubMed Web of Science ®Google Scholar
• Kausch W. Das Carcinom der Papilla Duodeni and seine radikale Entfeinung. Beitrage zur Klinishe Chirurgie 1912;78: 439–86.
   Google Scholar
• Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the Ampulla of Vater. Ann Surg. 1935;102:763–79.
   PubMedGoogle Scholar
• Crile G Jr. The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970;130:1049–53.
   PubMedGoogle Scholar
• Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447–58.
   PubMed Web of Science ®Google Scholar
• Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993;217:430–5.
   PubMed Web of Science ®Google Scholar
• Conlon KC, Dougherty E, Klimstra DS, Coit DG, Turnbull AD, Brennan MF. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg. 1996;223:134–40.
   PubMed Web of Science ®Google Scholar
• Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978; 146:959–62.
   PubMedGoogle Scholar
• Bell RH Jr. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treat Rev. 2005;31:328–31.
   PubMed Web of Science ®Google Scholar
• Satake K, Nishiwaki H, Yokomatsu H, Kawazoe Y, Kim K, Haku A, . Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet. 1992;175:259–65.
   PubMedGoogle Scholar
• Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, . Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228: 508–17.
   PubMed Web of Science ®Google Scholar
• Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J, . Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma– part 3: Update on 5-year survival. J Gastrointest Surg 2005;9: 1191–204.
   PubMed Web of Science ®Google Scholar
• Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, Pancreas Cancer Working Group. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138:618–28; Discussion 628–30.
   PubMed Web of Science ®Google Scholar
• Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, Zhao Q, . Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery. 2007;142:572–8.
   PubMed Web of Science ®Google Scholar
• Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133:521–7.
   PubMed Web of Science ®Google Scholar
• Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt MC, Merchant NB, . Left-sided pancreatectomy: A multicenter comparison of laparoscopic and open approaches. Ann Surg. 2008;248:438–46.
   PubMed Web of Science ®Google Scholar
• Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ, . Fatty pancreas: A factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058–64.
   PubMed Web of Science ®Google Scholar
• Sarr MG. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: A prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg. 2003;196:556–64.
   PubMed Web of Science ®Google Scholar
• Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, . Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 2000;232: 419–29.
   PubMed Web of Science ®Google Scholar
• Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, . Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–72.
   PubMed Web of Science ®Google Scholar
• Yeo CJ, Barry MK, Sauter PK, Sostre S, Lillemoe KD, Pitt HA, . Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg. 1993;218:229–37.
   PubMed Web of Science ®Google Scholar
• Hartel M, Wente MN, Hinz U, Kleeff J, Wagner M, Müller MW, . Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg. 2005;140:1094–9.
   PubMedGoogle Scholar
• Lillemoe KD, Kaushal S, Cameron JL, Sohn TA, Pitt HA, Yeo CJ. Distal pancreatectomy: Indications and outcomes in 235 patients. Ann Surg. 1999;229:693–8.
   PubMed Web of Science ®Google Scholar
• Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, . Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: Is cure possible? Ann Surg 2008;247:456–62.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Ko CY, Tomlinson JS, Stewart AK, Winchester DP, . Multimodality therapy for pancreatic cancer in the U. S.: Utilization, outcomes, and the effect of hospital volume. Cancer. 2007;110:1227–34.
   PubMed Web of Science ®Google Scholar
• Roldan GE, Gunderson LL, Nagorney DM, Martin JK, Ilstrup DM, Holbrook MA, . External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer. 1988;61:1110–6.
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006–10.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, . Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial. Lancet. 2001;358:1576–85.
   PubMed Web of Science ®Google Scholar
• Klaassen DJ, MacIntyre JM, Catton GE, Engstrom PF, Moertel CG. Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil–an Eastern Cooperative Oncology Group study. J Clin Oncol. 1985;3:373–8.
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Dobelbower R Jr, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, . A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys. 2005;62:1345–50.
   PubMed Web of Science ®Google Scholar
• Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, . Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA. 2007;297:267–77.
   PubMed Web of Science ®Google Scholar
• Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol. 1997;15:2403–13.
   PubMed Web of Science ®Google Scholar
• Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 2003;185:476–80.
   PubMed Web of Science ®Google Scholar
• Linehan DC, Tan MC, Strasberg SM, Drebin JA, Hawkins WG, Picus J, . Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: A single-institution phase II study. Ann Surg. 2008;248:145–51.
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Dixon E. AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and overview of the conference. Ann Surg Oncol. 2009;16:1725–6.
   PubMed Web of Science ®Google Scholar
• Moutardier V, Magnin V, Turrini O, Viret F, Hennekinne-Mucci S, Gonçalves A, . Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2004;60:437–43.
   PubMed Web of Science ®Google Scholar
• Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, . Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335–9.
   PubMed Web of Science ®Google Scholar
• Pisters PWT, Wolff RA, Crane CH, Evans DB. Combined-modality treatment for operable pancreatic adenocarcinoma. Oncology 2005; 19:393–404, 409.
   PubMed Web of Science ®Google Scholar
• Abrams RA, Lowy AM, O’Reilly EM, Wolff RA, Picozzi VJ, Pisters PW. Combined modality treatment of resectable and borderline resectable pancreas cancer: Expert consensus statement. Ann Surg Oncol. 2009;16:1751–6.
   PubMed Web of Science ®Google Scholar
• Cartwright TH, Cohn A, Varkey JA, Chen YM, Szatrowski TP, Cox JV, . Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. J Clin Oncol. 2002;20:160–4.
   PubMed Web of Science ®Google Scholar
• Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 1989;30:1132–5.
   PubMed Web of Science ®Google Scholar
• Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet. 1994;344:1655–60.
   PubMed Web of Science ®Google Scholar
• VanHeek NT, De Castro SM, vanEijck CH, vanGeenen RC, Hesselink EJ, Breslau PJ, . The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: A prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003;238: 894–902.
   PubMed Web of Science ®Google Scholar
• Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J, . Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999;230: 322–8.
   PubMed Web of Science ®Google Scholar
• Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993;217: 447–55.
   PubMed Web of Science ®Google Scholar
• Wong GY, Schroeder DR, Carns PE, Yeo CJ, Pitt HA, Sauter PK. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: A randomized controlled trial. JAMA. 2004;291:1092–9.
   PubMed Web of Science ®Google Scholar
• Levy MJ, Wiersema MJ. EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 2003;57: 923–30.
   PubMed Web of Science ®Google Scholar